Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Other 1

Conditions

Endometrial Neoplasms 3Endometrial Hyperplasia 2Obesity 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Progestins × Clear all
NCT06914297 2026-06-04

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Fudan University

Phase 2 Recruiting
10 enrolled
Gynecologic

Endometrial Neoplasms

NCT07377734 2026-03-30

2026ColECFerSp

Peking University People's Hospital

Phase 2 Recruiting
30 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT05903131 2026-01-20

Uterine Preservation Via Lifestyle Transformation

Washington University School of Medicine

Phase 2 Recruiting
96 enrolled
GynecologicOther

Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡